You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 4, October 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

25-Hydroxycholecalciferol

The Probable Metabolically Active Form of Vitamin D3: Its Identification and Subcellular Site of Action

H. F. DeLuca, PhD

Arch Intern Med. 1969;124(4):442-450.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has been assumed from the early work of Askew et al1 and Windaus and co-workers2,3 that vitamins D2 and D3 act directly in the organism without molecular change. Experiments by Kodicek4,5 first demonstrated that vitamin D is in fact metabolized to biologically inactive "break down products" and lent further support to this assumption. In their hands, no evidence could be obtained for a biologically active metabolite of the vitamin. Clearly, their experiments were hindered by the low specific activity of vitamin D2 labeled with radioactive carbon (14C) and by inadequate chromatographic methods so as to preclude the detection of a major biologically active metabolite. With the development of new and powerful chromatographic techniques 6,7 and the synthesis of a radioactive vitamin D preparation of high enough specific activity 8-10 to allow experiments with physiologic doses of the vitamin, the question of vitamin . . . [Full Text PDF of this Article]


Author Affiliations

Madison, Wis

From the Biochemistry Department, University of Wisconsin, Madison. Dr. DeLuca is a Steenbock research professor.


Footnotes

Received for publication June 11, 1969; accepted July 16.

Read before the Conference on Divalent Ion Metabolism and Osteodystrophy in Chronic Renal Failure, Santa Barbara, Calif, Nov 18, 1968.

Reprint requests to Biochemistry Department, University of Wisconsin, Madison 53706 (Dr. DeLuca).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.